A synthetic anti-inflammatory glucocorticoid derived from cortisone. It is biologically inert and converted to prednisolone in the liver.
Prednisone was granted FDA approval on 21 February 1955.
Prednisone is indicated as an anti-inflammatory or immunosuppressive drug for allergic, dermatologic, gastrointestinal, hematologic, ophthalmologic, nervous system, renal, respiratory, rheumatologic, infectious, endocrine, or neoplastic conditions as well as in organ transplant.
MD Anderson in Katy, Houston, Texas, United States
M D Anderson Cancer Center, Houston, Texas, United States
MD Anderson in Sugar Land, Sugar Land, Texas, United States
Chinese PLA General Hospital, Beijing, China
Tongji hospital, Wuhan, Hubei, China
Univesity of Wisconsin, Madison, Wisconsin, United States
Roswell Park Cancer Institute, Buffalo, New York, United States
The University of Chicago, Chicago, Illinois, United States
University Hospital of Cologne, Cologne, Germany
Sun Yat-sen University Cancer Center, GuangZhou, Guangdong, China
Shneider children Hospital Nephrology Institute, Petach-Tikva, Israel
M D Anderson Cancer Center, Houston, Texas, United States
Henri Mondor Hospital, Creteil, France
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.